levothyroxine sodium 0.025 mg oral tablet
1 INDICATIONS AND USAGE Hypothyroidism Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as a replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression Levothyroxine sodium tablets are indicated in adult and pediatric patients, including neonates, as an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. Limitations of Use Levothyroxine sodium tablets are not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients as there are no clinical benefits and overtreatment with levothyroxine sodium tablets may induce hyperthyroidism [see Warnings and Precautions ( 5.1 )] . Levothyroxine sodium tablets are not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. Levothyroxine sodium tablet is a L-thyroxine (T4) indicated in adult and pediatric patients, including neonates, for: Hypothyroidism: As replacement therapy in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism. ( 1 ) Pituitary Thyrotropin (Thyroid-Stimulating Hormone, TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of thyrotropin-dependent well-differentiated thyroid cancer. ( 1 ) Limitations of Use not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis.
lupin pharmaceuticals, inc.
ROUND PURPLE L25
L25 ROUND PURPLE
Related Pills
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
Levothyroxine Sodium 0.088 MG Oral Tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
levothyroxine sodium 0.025 mg oral tablet
lupin pharmaceuticals, inc.
Levothyroxine Sodium 0.05 MG Oral Tablet
Lupin Pharmaceuticals, Inc.
Levothyroxine Sodium 0.1 MG Oral Tablet
Lupin Pharmaceuticals, Inc.
lamotrigine 25 MG Chewable Tablet
Taro Pharmaceuticals U.S.A., Inc.
Divalproex Sodium 250 MG Delayed Release Oral Tablet
unichem pharmaceuticals (usa), inc.
aripiprazole 20 mg
Alembic Pharmaceuticals Inc.
aripiprazole 30 mg
Alembic Pharmaceuticals Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING How Supplied
LEVOTHYROXINE SODIUM tablets USP are round, colored, scored and debossed with following debossing details on one side and break-line on other side. They are supplied as follows: Strength (mcg) Color/Shape Debossing Details NDC# for bottles of 90 NDC # for bottles of 100 NDC # for bottles of 500 NDC # for bottles of 1000 25 peach/round L15 68180-965-09 68180-965-01 68180-965-02 68180-965-03 50 white/round L16 68180-966-09 68180-966-01 68180-966-02 68180-966-03 75 violet/round L17 68180-967-09 68180-967-01 68180-967-02 68180-967-03 88 olive/round L19 68180-968-09 68180-968-01 68180-968-02 68180-968-03 100 yellow/round L20 68180-969-09 68180-969-01 68180-969-02 68180-969-03 112 Rose/round L21 68180-970-09 68180-970-01 68180-970-02 68180-970-03 125 tan/round L22 68180-971-09 68180-971-01 68180-971-02 68180-971-03 137 turquoise/round L23 68180-972-09 68180-972-01 68180-972-02 68180-972-03 150 blue/round L24 68180-973-09 68180-973-01 68180-973-02 68180-973-03 175 lilac/round L25 68180-974-09 68180-974-01 68180-974-02 68180-974-03 200 pink/round L26 68180-975-09 68180-975-01 68180-975-02 68180-975-03 300 green/round L27 68180-976-09 68180-976-01 68180-976-02 68180-976-03 Storage and Handling Store at 25°C (77°F); excursions permitted to 15° to 30°C (59° to 86° F) [see USP Controlled Room Temperature].
LEVOTHYROXINE SODIUM tablets USP should be protected from light and moisture.
More pills like ROUND L25